- Home
- APPF vs ASND Comparison
APPF vs ASND Comparison
Compare APPF & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPF
- ASND
- Stock Information
- Founded
- APPF 2006
- ASND 2006
- Country
- APPF United States
- ASND Denmark
- Employees
- APPF N/A
- ASND N/A
- Industry
- APPF Computer Software: Prepackaged Software
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- APPF Technology
- ASND Health Care
- Exchange
- APPF Nasdaq
- ASND Nasdaq
- Market Cap
- APPF 8.1B
- ASND 7.7B
- IPO Year
- APPF 2015
- ASND 2015
- Fundamental
- Price
- APPF $217.05
- ASND $123.00
- Analyst Decision
- APPF Buy
- ASND Strong Buy
- Analyst Count
- APPF 6
- ASND 13
- Target Price
- APPF $270.67
- ASND $195.92
- AVG Volume (30 Days)
- APPF 309.0K
- ASND 391.4K
- Earning Date
- APPF 10-24-2024
- ASND 11-05-2024
- Dividend Yield
- APPF N/A
- ASND N/A
- EPS Growth
- APPF N/A
- ASND N/A
- EPS
- APPF 3.53
- ASND N/A
- Revenue
- APPF $762,368,000.00
- ASND $340,327,869.00
- Revenue This Year
- APPF $28.01
- ASND $16.12
- Revenue Next Year
- APPF $19.32
- ASND $87.44
- P/E Ratio
- APPF $61.28
- ASND N/A
- Revenue Growth
- APPF 33.12
- ASND 166.54
- 52 Week Low
- APPF $164.29
- ASND $86.55
- 52 Week High
- APPF $274.56
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- APPF 50.23
- ASND 39.09
- Support Level
- APPF $209.37
- ASND $124.02
- Resistance Level
- APPF $216.42
- ASND $133.97
- Average True Range (ATR)
- APPF 7.65
- ASND 3.67
- MACD
- APPF 1.30
- ASND -0.33
- Stochastic Oscillator
- APPF 55.16
- ASND 15.18
About APPF AppFolio Inc.
AppFolio Inc is a provider of cloud-based software solutions for real estate industry. Its property management software provides property managers with an end-to-end solution to their business needs. Its products include cloud-based property management software (Appfolio Property Manager). It also offers value-added services, such as screening, risk mitigation and electronic payment services. The business activity of the firm predominantly functions through the United States and it generates revenue in the form of subscription fees.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.